Coxir Intensive Egf Peptide Emulsion
NDC Package 73590-0072-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Coxir Intensive Egf Peptide (niacinamide, adenosine) emulsions is ■ Can be used daily, AM and PM. This formulation utilizes a emulsion delivery system. Marketed by Noksibcho Cosmetic Co., Ltd., this product is identified by NDC 73590-0072.

Identification & Billing

NDC Package Code
73590-0072-2
Package Description
1 CONTAINER in 1 CARTON / 100 mL in 1 CONTAINER (73590-0072-1)
Product Code
73590-0072
11-Digit Billing Format
73590007202

Clinical Specifications

Proprietary Name
Coxir Intensive Egf Peptide
Non-Proprietary Name
Niacinamide, Adenosine
Substance Name
Adenosine; Niacinamide
Dosage Form
Emulsion - A dosage form consisting of a two-phase system comprised of at least two immiscible liquids1, one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. (Note: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment.)
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
■ Can be used daily, AM and PM. Gently massage onto face in circular motions untill absorbed.

Regulatory & Marketing

Labeler Name
Noksibcho Cosmetic Co., Ltd.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
07-01-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73590-0072-2 identifies a specific commercial package of 1 container in 1 carton / 100 ml in 1 container (73590-0072-1) of Coxir Intensive Egf Peptide, a human over the counter drug labeled by Noksibcho Cosmetic Co., Ltd.. This emulsion is formulated for topical use and contains adenosine; niacinamide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Noksibcho Cosmetic Co., Ltd. on July 01, 2021. The current certification is valid through December 31, 2026.

How is this Noksibcho Cosmetic Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73590007202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
73590-0072-2
11-Digit CMS (5-4-2)
73590-0072-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.